Word

ABRIVI THERAPEUTICS

Status

Pending

Status Code

638

Status Date

Wednesday, July 31, 2024

Serial Number

98341186

Mark Type

4

Filing Date

Thursday, January 4, 2024

Trademark Owner History

LYKOS THERAPEUTICS, INC. - 1st New Owner Before Publication
MAPS Public Benefit Corporation - Original Applicant

Classifications

5 Prescription psychotropic drugs; Midomafetamine (MDMA) preparations for medical purposes; Pharmaceutical preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions; Psychopharmaceutical preparations for managing and treating diseases, disorders, and conditions related to HPA axis dysregulation, trauma, mood, thought, behavior, and perception; Psychedelic therapeutic preparations for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury.

42 Medical scientific research and development in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals; Providing medical scientific research information in the fields of psychotropics, psychedelic-assisted therapy, and psychopharmaceuticals.

Trademark Events

Jan 4, 2024

New Application Entered

Apr 3, 2024

Automatic Update Of Assignment Of Ownership

Apr 21, 2024

New Application Office Supplied Data Entered

Jul 31, 2024

Assigned To Examiner

Aug 7, 2024

Assigned To Examiner

Sep 23, 2024

Assigned To Examiner